Induction of autocrine factor inhibiting cell motility from murine B16–Bl6 melanoma cells by α‐melanocyte stimulating hormone

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International Journal of Cancer

• Publication date

  1999-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19990315)80:6<889::AID-IJC15>3.0.CO;2-MPMID 10074923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell-contact and-architecture of malignant cells and their relationship to metastasis

  2004cited by this paper
• Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH.

  1997cited by this paper
• Anti-inflammatory actions of the neuroimmunomodulator α-MSH

  1997cited by this paper
• Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.

  1997cited by this paper
• The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro

  1996cited by this paper
• Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.

  1996cited by this paper
• The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro.

  1996cited by this paper
• Inhibition of cancer cell motility and invasion by interleukin-12

  1995cited by this paper
• Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model

  1995cited by this paper
• Characterisation of melanocortin receptor subtypes by radioligand binding analysis.

  1995cited by this paper
• The role of the extracellular matrix in tumor cell metastasis.

  1994cited by this paper
• cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases.

  1994cited by this paper
• Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma

  1994cited by this paper
• Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R.

  1994cited by this paper
• α‐Melanocyte‐Stimulating Hormone Peptides in Host Responses From Basic Evidence to Human Research a

  1993cited by this paper
• Alpha-melanocyte-stimulating hormone peptides in host responses. From basic evidence to human research.

  1993cited by this paper
• Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells.

  1992cited by this paper
• Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness.

  1992cited by this paper
• Molecular mechanisms of cell motility

  1992cited by this paper
• Differences in Chemotaxis to Fibronectin in Weakly and Highly Metastatic Tumor Cells

  1992cited by this paper
• Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

  1992cited by this paper
• Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice.

  1991cited by this paper
• Regulation of cell movement: the motogenic cytokines.

  1991cited by this paper
• Degradation of alpha‐melanocyte stimulating hormone (alpha‐MSH) by CALLA/endopeptidase 24. 11 expressed by human melanoma cells in culture

  1990cited by this paper
• Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.

  1989cited by this paper
• Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene.

  1988cited by this paper
• Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma model.

  1987cited by this paper
• α-Melanocyte-stimulating hormone stimulates the outgrowth of myelinated nerve fibers after peripheral nerve crush

  1986cited by this paper
• Tumor cell autocrine motility factor.

  1986cited by this paper
• Studies on the Cloudman melanoma cell line as a model for the action of MSH.

  1985cited by this paper
• Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy.

  1981cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Inhibition of cell motility by interferon.

  1980cited by this paper
• Motility of rat ascites hepatoma cells, with reference to malignant characteristics in cancer metastasis.

  1978cited by this paper

• Anti‐colon cancer activity tracking isolation of peptide from ginseng leaves and potential mechanisms evaluation in vitro and in vivo

  2021cites this paper
• Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.

  2015cites this paper
• In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy.

  2012cites this paper
• Effects of Lupeol on Melanoma In Vitro and In Vivo: Fundamental and Clinical Trials

  2010cites this paper
• The effect of poly (aspartic acid-co-lactic acid) nanospheres on the lung metastasis of B16BL6 melanoma cells by intravenous administration.

  2006cites this paper
• Gene Transfer of Pro-opiomelanocortin Prohormone Suppressed the Growth and Metastasis of Melanoma: Involvement of α-Melanocyte-Stimulating Hormone-Mediated Inhibition of the Nuclear Factor κB/Cyclooxygenase-2 Pathway

  2006cites this paper
• Gene Transfer of Pro-opiomelanocortin Prohormone Suppressed the Growth and Metastasis of Melanoma: Involvement of α-MSH-mediated Inhibition of NFκB/COX-2 Pathway

  2005cites this paper
• Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development

  2005cites this paper
• Remodeling of actin cytoskeleton in lupeol-induced B16 2F2 cell differentiation.

  2005cites this paper
• Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility

  2004cites this paper
• Phosphodiesterase inhibitors as anti-cancer drugs.

  2004cites this paper
• Melanocytic Colonization of a Meningothelial Meningioma: Histopathological and Ultrastructural Findings with Immunohistochemical and Genetic Correlation: Case Report

  2003cites this paper
• In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy.

  2002cites this paper
• Selective inhibition of the epidermal growth factor receptor by ZD1839 decreases the growth and invasion of ovarian clear cell adenocarcinoma cells.

  2002cites this paper
• Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs.

  2001cites this paper